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MOAKSAbstract Background: Osteoarthritis (OA) describes an age-related, heterogeneous group of dis-
orders characterized pathologically by focal areas of loss of articular cartilage in synovial joints,
associated with varying degrees of osteophyte formation, subchondral bone change, and synovitis.
Currently, cartilage repair remains a major challenge for physicians, being avascular with limited
regenerative capacity. Stem cell therapy opened new horizons for hyaline cartilage repair. Peripheral
blood stem cells (PBSC) due to their multi-lineage potential, immunosuppressive activities, and lim-
ited immunogenicity, were tried as an intra articular injection.
Aim of study: To ﬁnd out the regenerative effect of repeated intra articular injections of autologous
PBSC in knee joints of OA patients using MR cartilage imaging.
Methods: 10 patients (3 males and 7 females) diagnosed with bilateral knee joints OA were
included in this study, they underwent history taking, clinical examination and MR cartilage imag-
ing using the semi-quantitative whole joint assessment score of knee for OA (MOAKS). Three intra
articular injections of 8 ml of autologous PBSC in each knee were administered. Clinical and MRI
assessments were repeated after 1 year.
Results: A signiﬁcant reduction was seen in all parameters post injection. MR images analysis
showed increased cartilage thickness in 65 knee joint compartments out of 160 affected compart-
ments.
788 K.A. Ahmad et al.Conclusion: Limited good level of evidence showed that repeated intra-articular injections of autol-
ogous PBSC resulted in an improvement of the quality of articular cartilage repair and physical
function as observed by MRI and clinical assessment.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Osteoarthritis is a degenerative condition of the cartilage and
other tissues such as the synovium in which immunological
and inﬂammatory reactions occur contribute to the develop-
ment of joint pathology (1) and clinically, patients with
osteoarthritis (OA) express variable synovitis. Thickening of
the lining layer containing predominantly macrophages
produce elevated levels of pro-inﬂammatory factors and
damage-associated molecular pattern molecules (2).
The release of cartilage matrix fragments from damaged
cartilage may give a prolonged stimulation of synovial macro-
phages, thereby forming a positive feedback loop that drives
deleterious synovitis. This sheds new light on the potential
mechanism of action of mesenchymal stem cell (MSC) therapy
in osteoarthritis (1).
Although it is generally accepted that the primary effect of
stem cell treatment occurs through tissue-speciﬁc differentia-
tion, new data suggest that the therapeutic potential of these
cells might also be related to their paracrine effect (3,4).
Some orthopedists try to treat OA patients with biologic
reconstruction as soon as possible. Numerous procedures are
available. These procedures include micro fracture or micro
drilling surgery, autologous chondrocyte implantation (ACI),
mosaicplasty, and matrix-guided autologous chondrocyte
implantation, among other approaches (5).
However, the drawbacks of ACI include limited cell
sources, difﬁculty in phenotype retention, and donor-site
morbidity, all of which challenge autologous cell transfer
procedures. Thus, new strategies rely upon cell therapies that
explore the use of stem cells rather than primary chondrocytes
for cartilage regeneration (6).
Therefore this study of repeated intra articular injections of
PBSC in knees of OA patients without prior surgery will
declare whether this non invasive application will also help
to prevent joint destruction within the human OA joint.
Magnetic resonance imaging (MRI) provides high-spatial-
resolution, multiplanar imaging and excellent tissue contrast.
This enables a three-dimensional assessment of all components
of the joint simultaneously, allowing direct visualization of
articular cartilage. With the advances in techniques and devel-
opment of dedicated sequences, MRI has become the imaging
modality of choice in both clinical and research settings of
musculoskeletal diseases, in particular osteoarthritis (OA), a
chronic joint disease characterized by destruction and progres-
sive loss of articular cartilage and clinical symptoms including
pain, stiffness and impaired function (7).
2. Aim of the study
To ﬁnd out the regenerative effect of repeated intra articular
injections of autologous PBSC in knees of osteoarthritis
patients using MR cartilage imaging.3. Materials and methods
10 patients (3 males and 7 females; age range 38–64 years with
bilateral knee joints OA were included in this study which was
conducted during a period of one year, in a University Hospi-
tals. The research carried out here on human subjects was in
compliance with the Helsinki Declaration, and informed
consent was obtained from all study subjects.
Inclusion criteria: include osteoarthritis diagnosed by X-ray
and MRI and end stage osteoarthritis candidate for total knee
replacement.
Exclusion criteria: include pregnancy or lactating, positive
tests for HIV, HCV, and HBV, any bleeding disorders or
blood diseases, active neurologic disorder, end organ damage,
and uncontrolled endocrine disorders.
All patients underwent history taking and thorough clinical
examination with emphasis on:
1- WOMAC index (8) questionnaire to evaluate the condi-
tion of patients, including pain (0–20), stiffness (0–8),
and physical functioning of joints (0–68). 0 = None,
1 = Slight, 2 =Moderate, 3 = Very, 4 = Extremely
(11). WOMAC questionnaire is used before and
12 months after treatment.
2- The 6-min walk distance (6MWD) is a test where the
subject walks for 6 min on level ground, and the distance
covered in 6 min is measured (9).
3- Plain X-ray A–P and lateral views before treatment to
estimate joint space loss and any defect in bone or osteo-
phytes using Kellgren–Lawrence grading scale (10).
4- MRI with cartilage imaging technique, to measure the
thickness of the cartilage and number of affected com-
partments, presence of osteophytes, effusion, meniscal
extrusion before and 12 months after treatment Fig. 1.
3.1. MR acquisition
MR images of both knees were obtained for all patients with a
1.5-T (Achiva; Philips Medical Systems, Best, the Netherlands)
MR system with an extremity coil.
3.2. MR imaging protocol included
Sagittal dual echo TSE sequence TR/TE 3000/50 and 80 ms,
thickness, 3.5 mm; gap, 0.35 mm; matrix 256 · 200; FOV
170 · 170 · 84 mm. Sagittal and coronal intermediate
weighted SE sequence with fat suppression ‘‘SPAIR’’ TR/TE
3000/50 ms; thickness, 3.5 mm; gap, 0.35 mm; matrix,
256 · 200; FOV 170 · 170 · 77 mm. Coronal T1W_TSE (TR/
TE 500/17 ms; section thickness, 4 mm; gap, 0.4 mm; sections,
20; matrix, 292 · 165; FOV 180 · 153 · 88 mm. Axial mFFE
sequence ‘‘multislice fast ﬁeld echo’’ (TR/TE/delta TE, 940/
Fig. 1 (A) Sagittal fat suppressed intermediate weighted image (TE = 50 ms) along the lateral aspect of the knee joint. Normal cartilage
thickness and signal is demonstrated along the lateral femoral (anterior, central and posterior) sub regions. The normal cartilage exhibits
intermediate signal against the dark signal subchondral bone. (B) Sagittal fat suppressed intermediate weighted image of the same patient
along the medial aspect of the knee joint. Full thickness cartilage loss is demonstrated at the medial femoral (anterior and central) sub
regions. The posterior sub region shows lost articular cartilage along more than 50% of the sub region with a small area of intact residual
cartilage superiorly.
Fig. 2 (A) 3D WATS C axial image at the level of the patella. There is intact articular cartilage along the medial and lateral patellar
facets. The cartilage demonstrates a hyper intense signal, while the joint ﬂuid appears hypo intense. (B) 3D WATS F axial image was seen
at the same level as A in the same patient. The cartilage demonstrates an intermediate signal, while the joint ﬂuid appears hyper intense.
(C) 3D WATS C axial image was seen in a different patient. There is partial thickness cartilage loss along the medial patellar sub region,
while there is intact cartilage along the lateral patellar sub region.
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Fig. 3 Coronal fat suppressed intermediate weighted image
(TE = 50 ms) of the knee joint. There is subchondral marrow
edema along the femoral and tibial aspects, most appreciated at
the subspinous tibial region, extruded medial meniscus and loss of
articular cartilage at the medial compartment on both opposing
articular surfaces.
Table 1 WOMAC index results before treatment.
Variable Mean ± SD
Stiﬀness 6.2 ± 0.9
Pain 15.4 ± 2.4
Physical function limitations 51 + 7
Total WOMAC 72.7 ± 9
790 K.A. Ahmad et al.9.2/8.2 ms; thickness, 4 mm; gap 0.4 mm; matrix, 232 · 187,
FOV 160 · 160 · 88 mm. 3D_WATS F axial (TR/TE 20/
7.4 ms, over contiguous slices; sections, 60; matrix, 204 · 203;
FOV 140 · 140 · 90 mm. 3D_WATS C axial (TR/TE 20/
7.6 ms, over contiguous slices; sections, 60; matrix, 252 · 252;
FOV 150 · 150 · 90 mm Fig. 2.
3.3. MR Interpretation
MR examinations were selected for semi quantitative assess-
ment. Two radiologists (Y.I. and K.A.), who were blinded to
radiographic OA grade and clinical data, evaluated the MR
images by using MRI Osteoarthritis Knee Score (MOAKS)
(11).
Baseline and follow-up MR images were read in pairs, with
the chronological order known to the readers. The following
joint structures were assessed in this study: cartilage morphol-
ogy and signal intensity, subchondral bone marrow lesions,
meniscal status, effusion, and anterior cruciate ligament status.
Cartilage signal intensity and morphology were scored accord-
ing to the MOAKS system from 0 to 3 in ﬁve sub regions each
in the medial and lateral tibifemoral (TF) compartments, for a
total of 10 TF sub regions and two sub regions each in medial
and lateral patellofemoral compartments for a total of 4 sub
regions. The number of affected joint compartments was deter-
mined in each examined knee. On follow up scans, the number
of responding compartments that showed increased cartilage
thickness after treatment was also determined. The maximum
scores of cartilage loss and full thickness cartilage loss were
determined for each knee which is the maximum score
obtained in any sub region. The percentage of change of these
maximum scores was calculated in the pre and post-treatment
MRI scans. Osteophyte formation was scored from 0 to 3
according to the osteophyte size. Bone marrow lesions were
scored from 0 to 3 on the basis of the extent of regional
involvement. Meniscal status was graded from 0 to 3 in the
anterior horn, the body segment, and the posterior horn of
the medial and lateral menisci. The anterior cruciate ligament
was scored either as intact or torn. Joint effusion was graded
from 0 to 3 in terms of the estimated maximum distention of
the synovial cavity (11).
3.4. Statistical methodology
Analysis of data was done using SPSS v12 to describe quanti-
tative and qualitative variables. Wilcoxon signed test was used
in non-parametric data and paired t-test in parametric data.
Spearman correlation test was used to rank variables versus
each other’s positively or inversely.
4. Results
This study included 7 females and 3 males with moderate to
severe OA diagnosed by plain X-ray as asymmetrical loss of
joint space, osteophytes, and subchondral bone sclerosis. Their
mean age was 51 ± 13 years. range (38–64 years) and mean
BMI 32 ± 1.2.
Clinical knee examination revealed painful limited ﬂexion
110 in 8 patients while unlimited in 2. Genu varum deformi-
ties less than 10, MCL laxity and patellofemoral friction were
evident in all patients. 15% had moderate effusion withsynovial hypertrophy, while 50% had positive Mc Murray
test and further subjective evaluation of osteoarthritis by
WOMAC index was done 1 week prior to treatment by one
physiatrist and the results illustrated in (Table 1).
All patients performed the 6MWD test by the same physiat-
rist 1 week prior to treatment and mean distance measured was
306 ± 62 m range (200–400).
Plain X-ray of 20 knees revealed that all patients had radio-
logical features of OA, severity grades are listed as 10% of
knees was minimal grade, 50% was moderate and 40% was
severe.
MRI ﬁndings before PBSC injection, mean number of
affected compartments was 8 ± 2, while osteophyte scoring
was maximum 3 in all patients, effusion was mild in 80% of
knees, moderate in 10% and severe in 5% of knees while 5%
had no effusion. Ligaments/tendons assessment showed
MCL sprain was evident in 18 knees while 35% knees revealed
ACL tear. 2 patients had edematous subchondral lesions.
Other MRI ﬁndings, meniscal affection was evident in 95%
of knees. 55% of knees had grade 3 extrusion, 15% of knees
showed grade 2, while 30% showed grade 1 meniscal extrusion
Fig. 3.
The values of number of affected compartments in knees
prior to PBSC injection and number of responding compart-
ments post injection and comparison between them were illus-
trated in (Table 2).
Upon studying MRI ﬁndings with clinical tests, there were
signiﬁcant positive correlation between physical functional
Table 2 Comparison between number of affected and number
of responding compartments.
Variables Mean ± Z P
Number of aﬀected compartments 8 ± 2 3.919 60.01
Number of responding compartments 3.5 ± 1.8
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tion (Table 3). On the other hand, 6MWD test was not signif-
icantly correlated with meniscal extrusion score.
Twelve months Post PBSC intra articular injection from
day 1 in both knees, no signs of infection or post operative
complications were reported except swelling, warmth in knee,
difﬁculty in moving knee, and pain at injection site within
the ﬁrst 2 weeks. Most of the patients reported gradual
improvement; regarding pain, stiffness, walking on a ﬂat sur-
face and light domestic duties but not in ascending or descend-
ing stairs; starting after the 4th month and persisting till the
end of the study period; except one patient who showed no
improvement at the end of the study period and underwent
total knee replacement in his RT knee. Flexion ROM was
improved to 140 in the 8 patients, and effusion disappeared
in all patients. Post injection values of WOMAC score and
6MWD are expressed and compared to pre injection values
in (Table 4).
Table 4 showed that, stiffness, pain, functional limitation
and WOMAC score declined, while 6MWD increased post
treatment with statistically signiﬁcant difference in comparison
to pretreatment results using the paired test. WOMAC index
sections revealed a signiﬁcant reduction in all parameters with
maximum improvement in pain score as the percentage of
change was 29%. 6MWD was increased by more than 54 m
which reﬂect signiﬁcant improvement in physical function.
Moreover, post injection pain score was signiﬁcantly corre-
lated inversely with number of responding compartments
(r= 0.63, P 6 0.05).
Post injection analysis of MR images of cartilage thickness
were scored according to the MOAKS system from 0 to 3 in 14
sub regions. Improvement was expressed as a percentage of
change of the maximum scores and was calculated in the pre
and post treatment MRI scans. The mean percentage of
change of maximum score of cartilage loss was 33 ± 0.0 andTable 3 Correlation between functional limitations versus
number of affected compartments.
Variables Physical functional
Number of aﬀected compartments r P
0.59 60.05 NS
Table 4 Comparison between clinical parameters pre and post inje
Variables Pre (mean + SD) Post (mean +
Stiﬀness 6.2 + 0.9 5 + 1.5
Pain 15.4 + 2.4 11 + 2.8
Function limitation 51 + 7 43 + 6.5
WOMAC (total) 72.7 + 9 59 + 10
6 m WD 306 + 62 387 + 87the mean percentage of change of the maximum score of full
thickness cartilage loss was 44 + 27 Fig. 1.
Moreover, total WOMAC index was signiﬁcantly inversely
correlated with percentage of change of maximum score of full
thickness cartilage loss; denoting cartilage repair (r= 0.073,
P 6 0.05).
5. Discussion
Osteoarthritis (OA) is a progressive disorder of the joints
caused by gradual loss of articular cartilage, which naturally
possesses a limited regenerative capacity (12).
The goals of successful cartilage repair include reducing
pain, improving symptoms and long term function; preventing
early osteoarthritis and subsequent total knee replacements;
and rebuilding hyaline cartilage instead of ﬁbrous cartilage
(13).
Conventional treatment is aimed at reducing pain, main-
taining mobility and minimizing disability (1). However, till
date, no technique has reliably regenerated the biological com-
position and biomechanical properties of native cartilage, leav-
ing unresolved pain and loss of joint function for millions of
patients with defective cartilage from aging, injury, or disease.
Emerging evidence indicates that direct intra-articular injec-
tion of stem cells may boost the normally limited repair and
limit the destructive process (14).
In our study, the authors proposed autologous peripheral
blood stem cells (PBSC) as opposed to cultured MSC or mar-
row aspirate due to the ease of harvest and the increased
potential of this cell line. This in in congruency with a recent
study by Saw et al., who injected intra articular autologous
PBSC in combination with hyaluronic acid (HA) a cartilage
regeneration protocol (15).
In our study all patients with osteoarthritis had positive X-
ray ﬁndings suggestive from mild to severe OA. Subjective
assessment of the patients was done by the WOMAC index
as a reliable index of disability for OA and high scores which
indicate worse pain, stiffness, and functional limitations (16).
The mean of pain, stiffness and physical function scores was
6.2 ± 0.9, 15.4 ± 2.4 and 51 ± 7, respectively. 6MWD was
used as a predictor of functional outcomes in rehabilitation
purposes. It was originally designed as a ‘‘useful measure of
exercise capacity’’ by researchers working with patients dem-
onstrating chronic heart failure (9). In this study it was used
before injection to reveal functional disability as mean of
6MWD was 306 ± 62 which was lower than normal values (9).
We studied the relation between clinical parameters and
MRI ﬁndings, there was signiﬁcant positive correlation
between physical functional limitation and the number of
affected compartments before injection Table 2. This could
be explained by many activities of the WOMAC index; asction.
SD) % of change t P
17 4.8 <0.001 HS
29 8.4 <0.001 HS
24 9.3 <0.001 HS
19.1 13 <0.001 HS
26 6 <0.001 HS
792 K.A. Ahmad et al.going upstairs and downstairs, getting in/out of bath, heavy
domestic duties; which produce maximum compression of all
compartments.
Most of the patients reported gradual improvement in pain,
stiffness and physical function and this was clear when com-
pared with pre injection values in Table 4. The amount of
improvement was 29% and physical function improved by
24%. Moreover, comparing pretreatment values of 6MWD
with post treatment ones, revealed signiﬁcantly increased dis-
tance i.e. improved functional performance and post treatment
WOMAC index inversely correlated with percentage of change
of cartilage thickness i.e. cartilage repair (r= 0.073,
P 6 0.05).
Emadedin et al. reported another case series involving six
patients. They found that patients were partly satisﬁed, walk-
ing ability was slightly decreased 6 months post injection,Fig. 5 Sagittal intermediate density weighted image with fat supp
osteoarthritis before (A) and after (B) intraarticular injection of auto
edema at the medial central femoral sub region (grade 2) and the medi
signal abnormality that is down staged to grade 1 on the femoral side
Fig. 4 Axial 3D WATS of a knee of a 64 years old female with
autologous stem cells. (A) There is full thickness cartilage loss over mo
(grade 3 full thickness cartilage loss). (B) A thin rim of hyper intenseand this was coincident with an increase in cartilage thickness
and extension of the repair tissue over the subchondral bone
(12).
5.1. MR images
MRI allows comprehensive imaging of joint structures and
structural changes over time in patients with knee OA. A num-
ber of semi quantitative scoring methods and quantitative
technologies have been developed and validated. They have
been shown to be reliable in the assessment of structural
changes cross-sectional and longitudinal (17).
Meniscal degeneration was evident in 95% of examined
knees, while 55% of knees had grade 3 extrusion, 15% of
knees showed grade 2, and 30% showed grade1 meniscal
extrusion. Meniscal tear was found in one knee. The strongression (TE = 50 ms) of a knee of a 65 years old female with
logous stem cells. (A) Shows hyper intense subchondral marrow
al central tibial sub region (grade 3). (B) There is regression of the
and grade 2 of the tibial side.
osteoarthritis before (A) and after (B) intraarticular injection of
re than 75% of the surface area of the medial patellar sub region
cartilage signal formed denoting partial response to therapy.
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tion with consequent cartilage loss in the same compartment
in subjects with OA is well established (18,19).
In our study, we examined the patient’s articular cartilage
with MRI and accordingly cartilage thickness appeared to be
increased in 65 knee joint compartments out of 160 affected
compartments, indicating that injected stem cells participate
in repair of the damaged cartilage in OA knees Fig. 4. In the
study done by Emadedin et al., (12) cartilage thickness
appeared to be increased in three out of six patients following
intra articular injection of autologous MSC. This was similar
to our study regarding the way of articular cartilage assess-
ment as both studies used the semi quantitative scoring
methods.
This is in common with a recent study by Saw et al., who
concluded that after arthroscopic subchondral drilling into
grade 3 and 4 chondral lesions, postoperative intra-articular
injections of autologous PBSC in combination with HA
resulted in an improvement of the quality of articular cartilage
repair over the same treatment without PBSC, as shown by
histologic and MRI evaluation (20).
One recent study showed that MRI quantitative methodol-
ogy may be more sensitive to change during a 2-year observa-
tion period than the semi quantitative scoring methods to
assess cartilage loss in the context of clinical trials (21). This
relative lack of sensitivity to change compared with quantita-
tive methods is a known weakness of semi quantitative assess-
ments (22).
In the same study of Emadedin et al., there was decrease
in the size of edematous subchondral patches following the
intra-articular injection in the MRI images. In our study,
there was decrease in size in the edematous subchondral
lesions in two patients, in three compartments in one, and
two compartments in the other Fig. 5 and such effects can
be attributed to anti-inﬂammatory inﬂuences of the injected
stem cells. (23).
In our study MR images showed complete ACL tear in two
knees of two different patients and partial tear in one knee in
another one. An increased risk of subsequent cartilage loss for
knees with established OA and baseline complete anterior cru-
ciate ligament tears has been reported previously (24).
Repeated injection for 3 times were suggested in this study
as a compensatory method for other adjuvants such as HA to
overcome cells dilution and dispersion inside the joint cavity.
6. Conclusion
Limited good level of evidence showed that repeated intra-
articular injections of autologous PBSC resulted in an
improvement of the quality of articular cartilage repair and
physical function as observed from the MRI and clinical
assessment.
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